Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid delivered by microneedling for treatment of melasma
IRCT20180811040761N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in melasma, sponsored by Kerman University of Medical Sciences. Started Aug 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20180811040761N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180811040761N1.